MedTrace Logo

A Clinical Evaluation of Semen Quality Using the MiOXSYS™ System 2.0

NCT02839447 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2024-03-08

No results posted yet for this study

Summary

The purpose of this study is to determine if elevations in oxidative stress, as measured by oxidation-reduction potential (ORP), can distinguish between semen samples from men with abnormal semen parameters from those with normal semen parameters. Static ORP (sORP) results, measured by the MiOXSYS System- a novel technology, will be compared to the current World Health Organization (WHO) semen analysis parameters (5th Edition WHO Laboratory Manual for the Examination and Processing of Human Semen \[2010\]).

Conditions

  • Male Infertility

Interventions

DIAGNOSTIC_TEST

Diagnostic

Diagnostic

Sponsors & Collaborators

  • Aytu BioPharma, Inc.

    lead INDUSTRY

Eligibility

Min Age
21 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-09-30
Primary Completion
2026-01-31
Completion
2026-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02839447 on ClinicalTrials.gov